Multicenter clinical study evaluating safety and efficacy of iron chelation therapy in patients with transfusion-induced iron overload
Not Applicable
Recruiting
- Conditions
- Transfusion-induced iron overload
- Registration Number
- JPRN-UMIN000002515
- Lead Sponsor
- The National Research Group on Idiopathic Bone Marrow Failure Syndromes in Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with severe renal or hepatic dysfunction. Patients who are pregnant or breastfeeding or expecting pregnancy. Patients with history of hypersensitivity to deferasirox. Patients who have been judged as inappropriate for any reasons by the concerning investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluating hematopoietic improvement
- Secondary Outcome Measures
Name Time Method Evaluating improvement of other organ dysfunctions (hepatic dysfunction, cardiac dysfunction, glucose intolerance), and validity of the "Japanese guidelines for the treatment of transfusional iron overload"